Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis
International Journal of Biochemistry and Molecular Biology · 2024 · 15 (1) · 1-7
DOI: 10.62347/fvbs3902 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Biochemistry and Molecular Biology, 2024. Verfasst von Praveen Prashant. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Prashant, P. (2024). Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis. International Journal of Biochemistry and Molecular Biology, 15(1), 1-7. https://doi.org/10.62347/fvbs3902
Vancouver
Prashant P. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis. International Journal of Biochemistry and Molecular Biology. 2024;15(1):1-7. doi:10.62347/fvbs3902
BibTeX
@article{Prashant2024,
author = {Prashant, Praveen},
title = {Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis},
journal = {International Journal of Biochemistry and Molecular Biology},
year = {2024},
volume = {15},
number = {1},
pages = {1--7},
doi = {10.62347/fvbs3902}
}
EUVIMED